Dilated cardiomyopathy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Dilated cardiomyopathy}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==..." |
|||
| (13 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Dilated cardiomyopathy}} | |||
{{CMG}}; {{AE}}{{AIA}} | |||
== Overview == | |||
Patients with [[dilated cardiomyopathy|dilated cardiomyopathy (DCM)]] are recommended to perform lifestyle changes, [[Physical exercise|physical activity]], reduce [[Stress (medicine)|stress]], and adhere to their [[Medication|medications]]. Also, patients with DCM with high risk features for [[sudden cardiac death]] are usually referred for implantable cardioverter [[defibrillator]] (ICD) placement. | |||
== Secondary Prevention == | |||
For patients who suffer from [[dilated cardiomyopathy]], the following is recommended: | |||
* Follow the same recommendations for [[Prevention (medical)|primary prevention]] as lifestyle changes, [[Physical exercise|physical activity]], and reducing [[Stress (medicine)|stress]]. | |||
* Adherence to medications to avoid worsening of the condition. | |||
* Also, patients with DCM with high risk features for [[sudden cardiac death]] are usually referred for implantable cardioverter [[defibrillator]] (ICD) placement.<ref name="pmid28355432">{{cite journal |vauthors=Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LYT, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD |title=Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis |journal=JAMA Cardiol |volume=2 |issue=6 |pages=685–688 |date=June 2017 |pmid=28355432 |doi=10.1001/jamacardio.2017.0630 |url=}}</ref><ref name="pmid15152060">{{cite journal |vauthors=Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH |title=Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy |journal=N. Engl. J. Med. |volume=350 |issue=21 |pages=2151–8 |date=May 2004 |pmid=15152060 |doi=10.1056/NEJMoa033088 |url=}}</ref> | |||
==References== | ==References== | ||
| Line 9: | Line 17: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | |||
[[Category:Cardiomyopathy]] | |||
[[Category:Cardiology]] | |||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 20:50, 13 January 2020
|
Dilated cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dilated cardiomyopathy secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dilated cardiomyopathy secondary prevention |
|
Risk calculators and risk factors for Dilated cardiomyopathy secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Patients with dilated cardiomyopathy (DCM) are recommended to perform lifestyle changes, physical activity, reduce stress, and adhere to their medications. Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.
Secondary Prevention
For patients who suffer from dilated cardiomyopathy, the following is recommended:
- Follow the same recommendations for primary prevention as lifestyle changes, physical activity, and reducing stress.
- Adherence to medications to avoid worsening of the condition.
- Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.[1][2]
References
- ↑ Al-Khatib SM, Fonarow GC, Joglar JA, Inoue L, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD (June 2017). "Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis". JAMA Cardiol. 2 (6): 685–688. doi:10.1001/jamacardio.2017.0630. PMID 28355432. Vancouver style error: initials (help)
- ↑ Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (May 2004). "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy". N. Engl. J. Med. 350 (21): 2151–8. doi:10.1056/NEJMoa033088. PMID 15152060.